Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 8 Lysine Vasopressin
2. 8-lysine Vasopressin
3. Diapid
4. Lys Vasopressin
5. Lys-vasopressin
6. Lysine Vasopressin
7. Lysyl Vasopressin
8. Postacton
9. Vasopressin, 8-lysine
10. Vasopressin, Lysine
11. Vasopressin, Lysyl
1. Lysine Vasopressin
2. Lysipressin
3. Syntopressin
4. 50-57-7
5. Postacton
6. Diapid
7. Lysine Pitressin
8. 8-l-lysinevasopressin
9. L-lysine Vasopressin
10. Vasopressin-8-lysine
11. Vasopressin Pig
12. Vasopressin, 8-l-lysine-
13. (8-lysine)vasopressin
14. Vasopressin, 8-l-lysine
15. Vasopressin (lysine Form)
16. [lys8]-vasopressin
17. 8-l-lysine Vasopressin
18. 50-57-7 (free Base)
19. [8-lysine]vasopressin
20. Lysine-vasopressin
21. Dsstox_cid_28501
22. Dsstox_rid_82773
23. Dsstox_gsid_48575
24. L-cysteinyl-l-tyrosyl-l-phenylalanyl-l-glutaminyl-l-asparaginyl-l-cysteinyl-l-prolyl-l-lysylglycinamide Cyclic (1->6)-disulfide
25. Lipressina
26. Lypressine
27. Lypressinum
28. Lysopressin
29. Lipresina
30. Lysylvasopressin
31. (lys8)-vasopressin
32. Cas-50-57-7
33. (s)-n-((s)-6-amino-1-((2-amino-2-oxoethyl)amino)-1-oxohexan-2-yl)-1-((4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)pyrrolidine-2-carboxamide
34. L-8
35. Lipressina [dcit]
36. Lipresina [inn-spanish]
37. Lypressine [inn-french]
38. Lypressinum [inn-latin]
39. Unii-7czf3l922y
40. 3-(phenylalanine)-8-lysine Oxytocin
41. L-lysinamide,
42. Lysine-adh
43. Lypressin [usan:usp:inn:ban]
44. Ncgc00181743-01
45. Ncgc00181743-02
46. Lvp
47. Einecs 200-050-5
48. Brn 4648365
49. [lys8]avp
50. Schembl33287
51. 7czf3l922y
52. Gtpl2172
53. Chembl1200690
54. Dtxsid8048575
55. Chebi:94802
56. Cys-tyr-phe-gln-asn-cys-pro-lys-gly-nh2, Cyclic 1-6 Disulfide
57. Hy-p0004
58. Tox21_112902
59. Tox21_113427
60. [lys8]-vasopressinlysine Vasopressin
61. Mfcd00076754
62. Ccg-270620
63. Cs-5838
64. Db14642
65. (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide
66. Oxytocin, 3-(l-phenylalanine)-8-l-lysine-
67. Vasopressin, 8-l-lysine- (7ci,8ci,9ci)
68. C75370
69. L]carbonyl]-l-prolyl-n-(2-amino-2-oxoethyl)-
70. 076l754
71. Brd-k93331255-001-01-2
72. Q27082434
73. 1,2-dithia-5,8,11,14,17-pentaazacycloeicosane-10-propionamide
74. Cys-tyr-phe-gln-asn-cys-pro-lys-gly-nh2[disulfide Bridge: 1-6]
75. (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide
76. (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentazacycloeicos-4-yl]-oxomethyl]-2-pyrrolidinecarboxamide
77. 1-[[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentaazacycloeicos-4-y
78. 1-{[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-l-p Rolyl-l-lysylglycinamide
79. 19-amino-4-[2-[[5-amino-1-[(carbamoylmethyl)carbamoyl]pentyl]carbamoyl]-1-pyrrolidinylcarbonyl]-13-benzyl-7-(carbamoylmethyl)-16-p-hydroxybenzyl-6,9,12,15,18-pentaoxo- (6ci)
80. Glycinamide, L-cysteinyl-l-tyrosyl-l-phenylalanyl-l-glutaminyl-l-asparaginyl-l-cysteinyl-l-prolyl-l-lysyl-, Cyclic (1>6)-disulfide
81. L 8
82. L-cysteinyl-l-tyrosyl-l-phenylalanyl-l-glutaminyl-l-asparaginyl-l-cysteinyl-l-prolyl-l-lysylglycinamide Cyclic (1-6)-disulfide
| Molecular Weight | 1056.2 g/mol |
|---|---|
| Molecular Formula | C46H65N13O12S2 |
| XLogP3 | -3.9 |
| Hydrogen Bond Donor Count | 13 |
| Hydrogen Bond Acceptor Count | 16 |
| Rotatable Bond Count | 19 |
| Exact Mass | 1055.43170691 g/mol |
| Monoisotopic Mass | 1055.43170691 g/mol |
| Topological Polar Surface Area | 476 Ų |
| Heavy Atom Count | 73 |
| Formal Charge | 0 |
| Complexity | 1960 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 8 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antidiuretic Agents
Agents that reduce the excretion of URINE, most notably the octapeptide VASOPRESSINS. (See all compounds classified as Antidiuretic Agents.)
Hemostatics
Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. (See all compounds classified as Hemostatics.)
Vasoconstrictor Agents
Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)
H - Systemic hormonal preparations, excl. sex hormones and insulins
H01 - Pituitary and hypothalamic hormones and analogues
H01B - Posterior pituitary lobe hormones
H01BA - Vasopressin and analogues
H01BA03 - Lypressin
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Lypressin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lypressin, including repackagers and relabelers. The FDA regulates Lypressin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lypressin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lypressin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Lypressin supplier is an individual or a company that provides Lypressin active pharmaceutical ingredient (API) or Lypressin finished formulations upon request. The Lypressin suppliers may include Lypressin API manufacturers, exporters, distributors and traders.
click here to find a list of Lypressin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Lypressin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lypressin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lypressin GMP manufacturer or Lypressin GMP API supplier for your needs.
A Lypressin CoA (Certificate of Analysis) is a formal document that attests to Lypressin's compliance with Lypressin specifications and serves as a tool for batch-level quality control.
Lypressin CoA mostly includes findings from lab analyses of a specific batch. For each Lypressin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lypressin may be tested according to a variety of international standards, such as European Pharmacopoeia (Lypressin EP), Lypressin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lypressin USP).
LOOKING FOR A SUPPLIER?
